Want to see SG:T14 full AI Analyst Report?

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (T14) Revenue

8 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Revenue

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had a revenue of 936.73M in the quarter ending Jun 30, 2026, with -38.18%. This bring the company's revenue in the last twelve months to 4.71B, Increased -5.20%. In the fiscal year ending Dec 31, 2025, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had annual revenue of 4.92B with -32.70% growth.

Revenue (ttm)

4.71B

Revenue Growth

-18.50%

P/S Ratio

0.71

Revenue/Employee

$1,264,097

Employees

3,890

Market Cap

$3.50B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	4.92B	-2.39B	-32.70%
Dec 31, 2024	7.31B	-915.58M	-11.14%
Dec 31, 2023	8.22B	-26.94M	-0.33%
Dec 31, 2022	8.25B	1.34B	+19.42%
Dec 31, 2021	6.91B	303.89M	+4.60%
Dec 31, 2020	6.60B	-390.23M	-5.58%
Dec 31, 2019	6.99B	635.26M	+9.99%
Dec 31, 2018	6.36B	669.38M	+11.77%
Dec 31, 2017	5.69B	―	―